Potent topical corticosteroid
Fluocinonide
Brand names: Metosyn
Adult dose
Dose: Apply thinly OD–QDS
Route: Topical
Frequency: OD-QDS
Clinical pearls
- Resistant inflammatory dermatoses
Contraindications
- Untreated infection
- Rosacea
- Acne
Side effects
- Skin atrophy
- Local irritation
- HPA suppression
Reference: BNF; https://bnf.nice.org.uk/drugs/fluocinonide/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD